IXICO plc Total Voting Rights (2665E)
03 11월 2015 - 12:38AM
UK Regulatory
TIDMIXI
RNS Number : 2665E
IXICO plc
02 November 2015
2 November 2015
IXICO plc
Total Voting Rights
In accordance with the requirements of the FCA's Disclosure and
Transparency Rule 5.6.1, IXICO plc (Ticker: IXI) ('IXICO' or the
'Company') confirms that the Company's issued share capital
consists of 15,215,664 ordinary shares of 50p each in issue, each
with equal voting rights. No shares are held in treasury.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine whether they are
required to notify their interest, or a change to their interest,
in the Company under the FCA's Disclosure and Transparency
Rules.
Enquiries:
IXICO plc +44 20 3763 7499
Derek Hill, CEO
Susan Lowther, CFO
Charles Spicer, VP Corporate Development
Peel Hunt LLP (Nominated Adviser and Broker) +44 20 7418 8900
James Steel
Oliver Jackson
Daniel Stewart & Company (Joint Broker) +44 207 776 6550
Martin Lampshire
David Coffman
FTI Consulting Limited (Investor Relations) +44 20 3727 1000
Simon Conway
Mo Noonan
Matthew Moss
Notes to Editors
About IXICO
IXICO, the brain health company, uses its innovative and
proprietary digital platform technologies to help those involved in
researching and treating serious diseases to make rapid, informed
decisions targeted at improving patient outcomes. IXICO has
significant experience working with global pharmaceutical and
biotechnology companies supporting clinical studies in the field of
neuro-degenerative disorders including dementia, Alzheimer's
disease, Huntington's disease and Multiple Sclerosis.
More information is available on www.ixico.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRUGGMWGUPAGAP
(END) Dow Jones Newswires
November 02, 2015 10:38 ET (15:38 GMT)
Phytopharm (LSE:PYM)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Phytopharm (LSE:PYM)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
Phytopharm (런던증권거래소)의 실시간 뉴스: 최근 기사 0
More Phytopharm News Articles